The CBD oil & CBD consumer health market size was exhibited at USD 81.19 billion in 2024 and is projected to hit around USD 546.21 billion by 2034, growing at a CAGR of 21.0% during the forecast period 2025 to 2034.
The U.S. CBD oil & CBD consumer health market size is evaluated at USD 34.1 billion in 2024 and is projected to be worth around USD 229.41 billion by 2034, growing at a CAGR of 18.92% from 2025 to 2034.
North America CBD oil & CBD consumer health market dominated the global market with a revenue share of 55.3% in 2024. Market growth in the region is its progressive regulatory landscape and wider acceptance of cannabis-derived products. A high concentration of CBD companies fosters innovation and product diversity, while increased consumer awareness of CBD’s health benefits drives demand. The legalization of hemp cultivation under the Farm Bill further accelerates market growth.
U.S. CBD Oil & CBD Consumer Health Market Trends
The CBD oil & CBD consumer health market in the U.S. dominated North America with the largest revenue share in 2024. The presence of leading manufacturers enables swift product innovation and availability. In addition, growing consumer interest in natural health solutions and favorable regulations enhance accessibility, leading to higher adoption rates among consumers seeking effective wellness products.
Europe CBD Oil & CBD Consumer Health Market Trends
Europe CBD oil & CBD consumer health market held substantial market share in 2024. The evolving regulatory landscape provides clearer guidelines for CBD usage, fostering investment and product development. Furthermore, a heightened focus on health and wellness among European consumers is driving demand for natural remedies, supporting overall market growth.
The CBD oil & CBD consumer health market in Germany is expected to grow rapidly in the forecast period. The country has established itself as a leader in regulatory frameworks for cannabis products, ensuring safe consumer access. Moreover, rising public awareness of CBD’s therapeutic benefits contributes to increasing demand, positioning Germany as a key player in the European market.
Asia Pacific CBD Oil & CBD Consumer Health Market Trends
Asia Pacific CBD oil & CBD consumer health market is expected to register the fastest CAGR of 39.3% in the forecast period, added by increasing legalization efforts and growing consumer interest in natural health products. Countries such as Australia and Japan are experiencing heightened awareness of cannabinoid benefits, leading to higher adoption rates. Moreover, a burgeoning middle class with disposable income enhances demand for wellness products, further boosting market potential.
The CBD oil & CBD consumer health market in China dominated the Asia Pacific CBD oil & CBD consumer health market in 2024 due to rising disposable incomes and an expanding middle class that prioritizes health and wellness. Government focus on healthcare initiatives promotes cannabinoid benefit awareness, especially among older populations seeking pain relief solutions. Moreover, increased spending on nutraceuticals establishes China as a significant player in the Asia Pacific market.
Report Coverage | Details |
Market Size in 2025 | USD 98.24 Billion |
Market Size by 2034 | USD 546.21 Billion |
Growth Rate From 2025 to 2034 | CAGR of 21.0% |
Base Year | 2024 |
Forecast Period | 2025-2034 |
Segments Covered | Product, Region |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
Key Companies Profiled | CVSciences, Inc.; Medical Marijuana, Inc.; Charlotte’s Web; ENDOCA; Isodiol International Inc; Elixinol; NuLeaf Naturals, LLC; Joy Organics; Kazmira; Lord Jones; AURORA CANNABIS INC.; Canopy Growth Corporation |
CBD consumer health products dominated the market and accounted for a share of 56.0% in 2024, owing to heightened consumer awareness of the health benefits associated with cannabidiol (CBD) products, including anxiety relief and pain management. As individuals increasingly seek natural alternatives to pharmaceuticals, CBD-infused items such as edibles, topicals, and supplements have gained traction. Favorable regulations and diverse product offerings further bolster consumer confidence and accessibility through e-commerce.
CBD oil products are expected to grow at the fastest CAGR of 20.9% over the forecast period. Consumers favor CBD oil for its ease of use and rapid absorption, making it a preferred solution for chronic pain and sleep disorders. Improvements in extraction methods have enhanced product quality, while the self-care trend drives interest in natural remedies over synthetic medications.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the CBD oil & CBD consumer health market
By Product
By Regional
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. CBD Oil & CBD Consumer Health Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. CBD Oil & CBD Consumer Health Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2034
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2034 (USD Million)
4.4. CBD Oil Market
4.4.1. CBD Oil Market, 2021 - 2034 (USD Million)
4.4.2. CBD Oil
4.4.2.1. CBD Oil Market, 2021 - 2034 (USD Million)
4.4.3. CBD Isolate
4.4.3.1. CBD Isolate Market, 2021 - 2034 (USD Million)
4.4.4. Synthetic CBD
4.4.4.1. Synthetic CBD Market, 2021 - 2034 (USD Million)
4.5. CBD Consumer Health Market
4.5.1. CBD Consumer Health Market, 2021 - 2034 (USD Million)
4.5.2. Medical OTC Products
4.5.2.1. Medical OTC Products Market, 2021 - 2034 (USD Million)
4.5.2.2. Analgesic
4.5.2.2.1. Analgesic Market, 2021 - 2034 (USD Million)
4.5.2.2.2. Oils
4.5.2.2.2.1. Oils Market, 2021 - 2034 (USD Million)
4.5.2.2.3. Pills/Capsules/Softgels
4.5.2.2.3.1. Pills/Capsules/Softgels Market, 2021 - 2034 (USD Million)
4.5.2.2.4. Topical
4.5.2.2.4.1. Topical Market, 2021 - 2034 (USD Million)
4.5.2.3. Mental Health
4.5.2.3.1. Mental Health Market, 2021 - 2034 (USD Million)
4.5.2.3.2. Oils
4.5.2.3.2.1. Oils Market, 2021 - 2034 (USD Million)
4.5.2.3.3. Pills/Capsules/Softgels
4.5.2.3.3.1. Pills/Capsules/Softgels Market, 2021 - 2034 (USD Million)
4.5.2.4. Dermatology
4.5.2.4.1. Dermatology Market, 2021 - 2034 (USD Million)
4.5.2.5. Sleep Aids
4.5.2.5.1. Sleep Aids Market, 2021 - 2034 (USD Million)
4.5.2.5.2. Oils
4.5.2.5.2.1. Oils Market, 2021 - 2034 (USD Million)
4.5.2.5.3. Pills/Capsules/Softgels
4.5.2.5.3.1. Pills/Capsules/Softgels Market, 2021 - 2034 (USD Million)
4.5.2.5.4. Oral Spray
4.5.2.5.4.1. Oral Spray Market, 2021 - 2034 (USD Million)
4.5.2.6. Others
4.5.2.6.1. Others Market, 2021 - 2034 (USD Million)
4.5.3. Nutraceuticals
4.5.3.1. Nutraceuticals Market, 2021 - 2034 (USD Million)
4.5.3.2. VDS
4.5.3.2.1. VDS Market, 2021 - 2034 (USD Million)
4.5.3.3. Sports Nutrition
4.5.3.3.1. Sports Nutrition Market, 2021 - 2034 (USD Million)
4.5.3.4. Weight Management and Well-being
4.5.3.4.1. Weight Management and Well-being Market, 2021 - 2034 (USD Million)
4.5.4. Food & Beverages
4.5.4.1. Food & Beverages Market, 2021 - 2034 (USD Million)
4.5.5. Pharmaceuticals
4.5.5.1. Pharmaceuticals Market, 2021 - 2034 (USD Million)
4.5.6. Personal Care & Cosmetics
4.5.6.1. Personal Care & Cosmetics Market, 2021 - 2034 (USD Million)
4.5.6.2. CBD Infused Skincare Products
4.5.6.2.1. CBD Infused Skincare Products Market, 2021 - 2034 (USD Million)
4.5.6.2.2. Creams & Moisturizers
4.5.6.2.2.1. Creams & Moisturizers Market, 2021 - 2034 (USD Million)
4.5.6.2.3. Masks & Serums
4.5.6.2.3.1. Masks & Serums Market, 2021 - 2034 (USD Million)
4.5.6.2.4. Cleansers
4.5.6.2.4.1. Cleansers Market, 2021 - 2034 (USD Million)
4.5.6.2.5. Sunscreen
4.5.6.2.5.1. Sunscreen Market, 2021 - 2034 (USD Million)
4.5.6.2.6. Bath Bombs
4.5.6.2.6.1. Bath Bombs Market, 2021 - 2034 (USD Million)
4.5.6.2.7. Others
4.5.6.2.7.1. Others Market, 2021 - 2034 (USD Million)
4.5.6.3. CBD Infused Beauty Products
4.5.6.3.1. CBD Infused Beauty Products Market, 2021 - 2034 (USD Million)
4.5.6.3.2. Lip Balm & Gloss
4.5.6.3.2.1. Lip Balm & Gloss Market, 2021 - 2034 (USD Million)
4.5.6.3.3. Mascara
4.5.6.3.3.1. Mascara Market, 2021 - 2034 (USD Million)
4.5.6.3.4. Eyebrow Gels
4.5.6.3.4.1. Eyebrow Gels Market, 2021 - 2034 (USD Million)
4.5.6.3.5. Others
4.5.6.3.5.1. Others Market, 2021 - 2034 (USD Million)
4.5.6.4. CBD Infused Haircare Products
4.5.6.4.1. CBD Infused Haircare Products Market, 2021 - 2034 (USD Million)
4.5.6.4.2. Shampoos
4.5.6.4.2.1. Shampoos Market, 2021 - 2034 (USD Million)
4.5.6.4.3. Conditioners
4.5.6.4.3.1. Conditioners Market, 2021 - 2034 (USD Million)
4.5.6.4.4. Hair Serums
4.5.6.4.4.1. Hair Serums Market, 2021 - 2034 (USD Million)
Chapter 5. CBD Oil & CBD Consumer Health Market: Regional Estimates & Trend Analysis
5.1. Regional Market Share Analysis, 2024 & 2034
5.2. Regional Market Dashboard
5.3. Market Size, & Forecasts Trend Analysis, 2021 to 2034:
5.4. North America
5.4.1. North America CBD Oil & CBD Consumer Health Market Estimates And Forecasts, By Country, 2021 - 2034 (USD Million)
5.4.2. U.S.
5.4.2.1. Key Country Dynamics
5.4.2.2. Regulatory Framework
5.4.2.3. Competitive Insights
5.4.2.4. U.S. CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.4.3. Canada
5.4.3.1. Key Country Dynamics
5.4.3.2. Regulatory Framework
5.4.3.3. Competitive Insights
5.4.3.4. Canada CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.4.4. Mexico
5.4.4.1. Key Country Dynamics
5.4.4.2. Regulatory Framework
5.4.4.3. Competitive Insights
5.4.4.4. Mexico CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.5. Europe
5.5.1. Europe CBD Oil & CBD Consumer Health Market Estimates And Forecasts, By Country, 2021 - 2034 (USD Million)
5.5.2. UK
5.5.2.1. Key Country Dynamics
5.5.2.2. Regulatory Framework
5.5.2.3. Competitive Insights
5.5.2.4. UK CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.5.3. Germany
5.5.3.1. Key Country Dynamics
5.5.3.2. Regulatory Framework
5.5.3.3. Competitive Insights
5.5.3.4. Germany CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.5.4. France
5.5.4.1. Key Country Dynamics
5.5.4.2. Regulatory Framework
5.5.4.3. Competitive Insights
5.5.4.4. France CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.5.5. Italy
5.5.5.1. Key Country Dynamics
5.5.5.2. Regulatory Framework
5.5.5.3. Competitive Insights
5.5.5.4. Italy CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.5.6. Croatia
5.5.6.1. Key Country Dynamics
5.5.6.2. Regulatory Framework
5.5.6.3. Competitive Insights
5.5.6.4. Croatia CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.5.7. Poland
5.5.7.1. Key Country Dynamics
5.5.7.2. Regulatory Framework
5.5.7.3. Competitive Insights
5.5.7.4. Poland CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.5.8. Netherlands
5.5.8.1. Key Country Dynamics
5.5.8.2. Regulatory Framework
5.5.8.3. Competitive Insights
5.5.8.4. Netherlands CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.5.9. Czech Republic
5.5.9.1. Key Country Dynamics
5.5.9.2. Regulatory Framework
5.5.9.3. Competitive Insights
5.5.9.4. Czech Republic CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.5.10. Switzerland
5.5.10.1. Key Country Dynamics
5.5.10.2. Regulatory Framework
5.5.10.3. Competitive Insights
5.5.10.4. Switzerland CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.6. Asia Pacific
5.6.1. Asia Pacific CBD Oil & CBD Consumer Health Market Estimates And Forecasts, By Country, 2021 - 2034 (USD Million)
5.6.2. Japan
5.6.2.1. Key Country Dynamics
5.6.2.2. Regulatory Framework
5.6.2.3. Competitive Insights
5.6.2.4. Japan CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.6.3. China
5.6.3.1. Key Country Dynamics
5.6.3.2. Regulatory Framework
5.6.3.3. Competitive Insights
5.6.3.4. China CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.6.4. India
5.6.4.1. Key Country Dynamics
5.6.4.2. Regulatory Framework
5.6.4.3. Competitive Insights
5.6.4.4. India CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.6.5. South Korea
5.6.5.1. Key Country Dynamics
5.6.5.2. Regulatory Framework
5.6.5.3. Competitive Insights
5.6.5.4. South Korea CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.6.6. Australia
5.6.6.1. Key Country Dynamics
5.6.6.2. Regulatory Framework
5.6.6.3. Competitive Insights
5.6.6.4. Australia CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.6.7. New Zealand
5.6.7.1. Key Country Dynamics
5.6.7.2. Regulatory Framework
5.6.7.3. Competitive Insights
5.6.7.4. New Zealand CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.7. Latin America
5.7.1. Latin America CBD Oil & CBD Consumer Health Market Estimates And Forecasts, By Country, 2021 - 2034 (USD Million)
5.7.2. Colombia
5.7.2.1. Key Country Dynamics
5.7.2.2. Regulatory Framework
5.7.2.3. Competitive Insights
5.7.2.4. Colombia CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.7.3. Brazil
5.7.3.1. Key Country Dynamics
5.7.3.2. Regulatory Framework
5.7.3.3. Competitive Insights
5.7.3.4. Brazil CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.7.4. Argentina
5.7.4.1. Key Country Dynamics
5.7.4.2. Regulatory Framework
5.7.4.3. Competitive Insights
5.7.4.4. Argentina CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.7.5. Chile
5.7.5.1. Key Country Dynamics
5.7.5.2. Regulatory Framework
5.7.5.3. Competitive Insights
5.7.5.4. Chile CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.7.6. Uruguay
5.7.6.1. Key Country Dynamics
5.7.6.2. Regulatory Framework
5.7.6.3. Competitive Insights
5.7.6.4. Uruguay CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.8. MEA
5.8.1. MEA CBD Oil & CBD Consumer Health Market Estimates And Forecasts, By Country, 2021 - 2034 (USD Million)
5.8.2. South Africa
5.8.2.1. Key Country Dynamics
5.8.2.2. Regulatory Framework
5.8.2.3. Competitive Insights
5.8.2.4. South Africa CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
5.8.3. Israel
5.8.3.1. Key Country Dynamics
5.8.3.2. Regulatory Framework
5.8.3.3. Competitive Insights
5.8.3.4. Israel CBD Oil & CBD Consumer Health Market Estimates And Forecasts, 2021 - 2034 (USD Million)
Chapter 6. Competitive Landscape
6.1. Participant Overview
6.2. Company Market Position Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.5. Company Profiles/Listing
6.5.1. CVSciences, Inc.
6.5.1.1. Overview
6.5.1.2. Financial Performance
6.5.1.3. Product Benchmarking
6.5.1.4. Strategic Initiatives
6.5.2. Medical Marijuana, Inc.
6.5.2.1. Overview
6.5.2.2. Financial Performance
6.5.2.3. Product Benchmarking
6.5.2.4. Strategic Initiatives
6.5.3. Charlotte’s Web
6.5.3.1. Overview
6.5.3.2. Financial Performance
6.5.3.3. Product Benchmarking
6.5.3.4. Strategic Initiatives
6.5.4. ENDOCA
6.5.4.1. Overview
6.5.4.2. Financial Performance
6.5.4.3. Product Benchmarking
6.5.4.4. Strategic Initiatives
6.5.5. Isodiol International Inc
6.5.5.1. Overview
6.5.5.2. Financial Performance
6.5.5.3. Product Benchmarking
6.5.5.4. Strategic Initiatives
6.5.6. Elixinol
6.5.6.1. Overview
6.5.6.2. Financial Performance
6.5.6.3. Product Benchmarking
6.5.6.4. Strategic Initiatives
6.5.7. NuLeaf Naturals, LLC
6.5.7.1. Overview
6.5.7.2. Financial Performance
6.5.7.3. Product Benchmarking
6.5.7.4. Strategic Initiatives
6.5.8. Joy Organics
6.5.8.1. Overview
6.5.8.2. Financial Performance
6.5.8.3. Product Benchmarking
6.5.8.4. Strategic Initiatives
6.5.9. Kazmira
6.5.9.1. Overview
6.5.9.2. Financial Performance
6.5.9.3. Product Benchmarking
6.5.9.4. Strategic Initiatives
6.5.10. Lord Jones
6.5.10.1. Overview
6.5.10.2. Financial Performance
6.5.10.3. Product Benchmarking
6.5.10.4. Strategic Initiatives
6.5.11. AURORA CANNABIS INC.
6.5.11.1. Overview
6.5.11.2. Financial Performance
6.5.11.3. Product Benchmarking
6.5.11.4. Strategic Initiatives
6.5.12. Canopy Growth Corporation
6.5.12.1. Overview
6.5.12.2. Financial Performance
6.5.12.3. Product Benchmarking
6.5.12.4. Strategic Initiatives